Annual Accounts Payable
$1.16 M
-$639.10 K-35.61%
December 1, 2023
Summary
- As of February 25, 2025, SKYE annual accounts payable is $1.16 million, with the most recent change of -$639.10 thousand (-35.61%) on December 1, 2023.
- During the last 3 years, SKYE annual accounts payable has risen by +$774.40 thousand (+203.04%).
- SKYE annual accounts payable is now -35.61% below its all-time high of $1.79 million, reached on December 1, 2022.
Performance
SKYE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$780.00 K
-$299.50 K-27.74%
September 1, 2024
Summary
- As of February 25, 2025, SKYE quarterly accounts payable is $780.00 thousand, with the most recent change of -$299.50 thousand (-27.74%) on September 1, 2024.
- Over the past year, SKYE quarterly accounts payable has stayed the same.
- SKYE quarterly accounts payable is now -64.35% below its all-time high of $2.19 million, reached on September 1, 2022.
Performance
SKYE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SKYE Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -35.6% | 0.0% |
3 y3 years | +203.0% | 0.0% |
5 y5 years | +7309.0% | 0.0% |
SKYE Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -35.6% | +28.4% | -64.3% | at low |
5 y | 5-year | -35.6% | +726.8% | -64.3% | +457.9% |
alltime | all time | -35.6% | >+9999.0% | -64.3% | -100.0% |
Skye Bioscience Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $780.00 K(-27.7%) |
Jun 2024 | - | $1.08 M(-1.4%) |
Mar 2024 | - | $1.10 M(-5.3%) |
Dec 2023 | $1.16 M(-35.6%) | $1.16 M(-29.6%) |
Sep 2023 | - | $1.64 M(-1.0%) |
Jun 2023 | - | $1.66 M(+24.9%) |
Mar 2023 | - | $1.33 M(-26.0%) |
Dec 2022 | $1.79 M(+99.4%) | $1.79 M(-18.0%) |
Sep 2022 | - | $2.19 M(+41.1%) |
Jun 2022 | - | $1.55 M(+71.7%) |
Mar 2022 | - | $902.70 K(+0.3%) |
Dec 2021 | $900.00 K(+136.0%) | $900.00 K(+165.5%) |
Sep 2021 | - | $339.00 K(-14.7%) |
Jun 2021 | - | $397.20 K(-22.1%) |
Mar 2021 | - | $509.90 K(+33.7%) |
Dec 2020 | $381.40 K(+172.8%) | $381.40 K(-49.3%) |
Sep 2020 | - | $753.00 K(-35.8%) |
Jun 2020 | - | $1.17 M(+20.0%) |
Mar 2020 | - | $978.20 K(+599.7%) |
Dec 2019 | $139.80 K(+796.2%) | $139.80 K(-32.4%) |
Sep 2019 | - | $206.90 K(+181.5%) |
Jun 2019 | - | $73.50 K(-56.3%) |
Mar 2019 | - | $168.30 K(+978.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $15.60 K(-84.5%) | $15.60 K(-74.2%) |
Sep 2018 | - | $60.50 K(-21.3%) |
Jun 2018 | - | $76.90 K(-61.3%) |
Mar 2018 | - | $198.80 K(+97.0%) |
Dec 2017 | $100.90 K(-63.3%) | $100.90 K(-89.8%) |
Sep 2017 | - | $990.10 K(+45.7%) |
Jun 2017 | - | $679.50 K(+199.1%) |
Mar 2017 | - | $227.20 K(-17.3%) |
Dec 2016 | $274.70 K(+119.1%) | $274.70 K(-29.1%) |
Sep 2016 | - | $387.40 K(+111.5%) |
Jun 2016 | - | $183.20 K(+33.3%) |
Mar 2016 | - | $137.40 K(+9.6%) |
Dec 2015 | $125.40 K(-69.4%) | $125.40 K(-5.1%) |
Sep 2015 | - | $132.20 K(-53.8%) |
Jun 2015 | - | $285.90 K(-26.3%) |
Mar 2015 | - | $388.10 K(-5.2%) |
Dec 2014 | $409.50 K(+2611.9%) | $409.50 K(>+9900.0%) |
Sep 2014 | - | $0.00(-100.0%) |
Jul 2014 | - | $6000.00(-60.3%) |
Oct 2013 | $15.10 K(+268.3%) | $15.10 K(+36.0%) |
Jul 2013 | - | $11.10 K(+16.8%) |
Apr 2013 | - | $9500.00(+131.7%) |
Oct 2012 | $4100.00 | $4100.00 |
FAQ
- What is Skye Bioscience annual accounts payable?
- What is the all time high annual accounts payable for Skye Bioscience?
- What is Skye Bioscience annual accounts payable year-on-year change?
- What is Skye Bioscience quarterly accounts payable?
- What is the all time high quarterly accounts payable for Skye Bioscience?
- What is Skye Bioscience quarterly accounts payable year-on-year change?
What is Skye Bioscience annual accounts payable?
The current annual accounts payable of SKYE is $1.16 M
What is the all time high annual accounts payable for Skye Bioscience?
Skye Bioscience all-time high annual accounts payable is $1.79 M
What is Skye Bioscience annual accounts payable year-on-year change?
Over the past year, SKYE annual accounts payable has changed by -$639.10 K (-35.61%)
What is Skye Bioscience quarterly accounts payable?
The current quarterly accounts payable of SKYE is $780.00 K
What is the all time high quarterly accounts payable for Skye Bioscience?
Skye Bioscience all-time high quarterly accounts payable is $2.19 M
What is Skye Bioscience quarterly accounts payable year-on-year change?
Over the past year, SKYE quarterly accounts payable has changed by $0.00 (0.00%)